Arrive Bio ^Company

Arrive Bio is a biotechnology company that focuses on developing therapies for age-related diseases. They utilize cutting-edge deep learning technology to analyze complex biological systems. Arrive has established partnerships with industry leaders such as Roche and the FDA. They are actively working with the FDA to set standards for AI algorithms in pathology. Arrive's unique approach combines machine learning, bioinformatics, and a proprietary knowledge database to enable in vivo target screening, improving the success rates of therapeutics for complex diseases.